# US 2005/0233383 A1 · Human olfactory receptors and genes encoding same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0233383 A1
- Document ID: US20050233383A1
- Status: Published application
- Kind: A1
- Application number: 10/819,316
- Filed: 2004-04-07
- Published: 2005-10-20
- Earliest claimed: 2000-03-13
- Assignees: Senomyx, Inc.
- Inventors: Sergey Zozulya
- Web page: https://patentgrep.com/patent/US20050233383A1

## CPC

- C07K 14/705: Receptors; Cell surface antigens; Cell surface determinants {(tumour specific antigens C07K14/4748)}
- G01N 33/566: using specific carrier or receptor proteins as ligand binding reagents {where possible specific carrier or receptor proteins are classified with their target compounds}
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The invention relates to cloned human olfactory receptors and the use thereof for identifying compounds that modulate olfaction.

## Claims

### Claim 1

A method for identifying the putative effect of a compound on olfactory perception in a mammal comprising the following:
(i) assaying the effect of one or more compounds that elicit a known effect on olfactory perception in a mammal in a cell-based assay that detects whether said one or more compounds modulate the activity of an olfactory receptor polypeptide encoded by a nucleic acid sequence having SEQ ID NO: 56 or an olfactory polypeptide which hybridizes under stringent hybridization conditions to said nucleic acid sequence, wherein said stringent hybridization conditions comprise hybridization in 50% formamide, 5×SSC, and 10% SDS, incubation at 42° C. with wash in 0.2×SSC and 0.1% SDS at 65° C., wherein said wash and hybridization step are each conducted for 1 minute; and
(ii) selecting compounds from step (i) that modulate the activity of said olfactory receptor polypeptide in said cell-based assay.

### Claim 2 (depends on 125)

The method of claim 125 which further includes an additional step wherein the effect of one or more compounds having an unknown effect on olfactory perception is screened in said cell-based assay and compounds are selected that enhance, inhibit or mimic the modulatory effect of said selected compound(s) having a known effect on olfactory perception on the activity of said olfactory receptor polypeptide in said cell-based assay.

### Claim 3 (depends on 125)

The method of claim 125 wherein the receptor polypeptide is encoded by a nucleic acid sequence having SEQ ID No: 56.

### Claim 4 (depends on 126)

The method claim 126 wherein said selected compound having an unknown effect on an olfactory perception mimics the modulatory effect of said selected one or more compounds that elicit a known effect on olfactory perception in a mammal on the activity of said olfactory receptor polypeptide.

### Claim 5 (depends on 127)

The method of claim 127 wherein said olfactory polypeptide is encoded by the nucleic acid sequence having SEQ ID NO: 56.

### Claim 6 (depends on 125)

The method of claim 125 wherein said one or more compounds that elicit a known effect on olfactory perception are fragrance compounds.

### Claim 7 (depends on 126)

The method of claim 126 wherein the one or more compounds having an unknown effect on olfactory perception in a mammal are comprised in a compound library.

### Claim 8 (depends on 131)

The method of claim 131 wherein said library is a combinatorial chemical library.

### Claim 9 (depends on 131)

The method of claim 131 wherein said library is a random combination of compounds.

### Claim 10 (depends on 126)

The method of claim 126 wherein said selected compound having a known effect on olfactory perception is a malodorant and the selected compound having an unknown effect on olfactory perception inhibits the modulatory effect of said compound on said olfactory receptor.

### Claim 11 (depends on 126)

The method of claim 126 wherein the selected one or more compounds enhance the modulatory effect of said compound having a known effect on olfactory perception on the activity of said olfactory receptor polypeptide.

### Claim 12 (depends on 125)

The method of claim 125 wherein the cell that expresses said olfactory receptor expresses a G protein that functionally couples to said receptor.

### Claim 13 (depends on 136)

The method of claim 136 wherein said G protein is Gα15 or Gα16.

### Claim 14 (depends on 125)

The method of claim 125 wherein the cell-based assay detects the effect of said one or more compounds on levels of intracellular calcium.

### Claim 15 (depends on 125)

The method of claim 125 wherein the cell-based assay detects the effect of said one or more compounds on the level of intracellular cyclic nucleotides.

### Claim 16 (depends on 125)

The method of claim 125 wherein the cell-based assay detects changes in intracellular calcium by detecting changes in FURA-2 dependent fluorescence in the cell.

### Claim 17 (depends on 125)

The method of claims 125 wherein the cell-based assay detects the transfer of 32p from gamma-labeled ATP to said olfactory receptor polypeptide.

### Claim 18 (depends on 125)

The method of claim 125 wherein said cell-based assay detects changes in electrophysiology of a cell or cell membrane expressing said olfactory polypeptide.

### Claim 19 (depends on 142)

The method of claim 142 wherein electrophysiology is detected by a voltage-clamp or patch-clamp technique.

### Claim 20 (depends on 125)

The method of claim 125 wherein the cell-based assay detects changes in total cell current by a radio labeled ion flux assay or fluorescence assay that detects changes in voltage by use of a voltage sensitive dye.

### Claim 21 (depends on 125)

The method of claim 125 wherein said cell-based assay detects changes in intracellular levels of second messengers.

### Claim 22 (depends on 145)

The method of claim 145 wherein said second messengers are selected from the group consisting of Ca2+, IP3, cGMP and cAMP.

### Claim 23 (depends on 146)

The method of claim 146 wherein said cell-based assay detects changes in inositol triphosphate (IP3).

### Claim 24 (depends on 125)

The method of claim 125 wherein the cell that expresses said olfactory receptor polypeptide is a HEK-293 cell line that expresses one or more chaperone proteins.

### Claim 25 (depends on 125)

The method of claim 125 wherein the cell that expresses said olfactory receptor polypeptide is a HEK-293 cell line that expresses a promiscuous G protein.

### Claim 26 (depends on 125)

The method of claim 125 wherein the cell-based assay detects the effect of said one or more compounds on the transcription of a gene of interest or reporter gene.

### Claim 27 (depends on 125)

The method of claim 125 wherein said one or more compounds that elicit a known effect on olfactory perception in a mammal are selected from the group consisting of perfumes, fragrances, deodorizing compounds, air freshener compounds, foods, drugs and compositions containing.

### Claim 28 (depends on 125)

The method of claim 125 wherein said method is used to identify compounds that block the smell olfactory effect elicited by said one or more compounds having a known effect on olfactory perception in a mammal.

### Claim 29 (depends on 125)

The method of claim 125 wherein said method is used to identify compounds that enhance or inhibit the olfactory effect of said one or more compounds having a known effect on olfactory perception in a mammal.

### Claim 30 (depends on 125)

The method of claim 125 wherein said one or more compounds are further screened in a cell-based assay that detects the effect of said one or more compounds on the activity of at least one other human olfactory receptor polypeptide.
